Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Depreciation & Amortization (CF) of $706000.0 for Q1 2026, down 16.65% on a YoY basis from $847000.0 in Q1 2025, and down 10.63% sequentially from $790000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $706000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 16.65% year-over-year to $706000.0; the trailing twelve-month figure through Mar 2026 stood at $3.1 million (down 8.58% YoY), and the FY2025 full-year result was $3.3 million, down 3.27% from the prior year.
- Depreciation & Amortization (CF) slipped to $706000.0 in Q1 2026, from $790000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $869000.0 in Q4 2024 to a low of $560000.0 in Q1 2022.
- A 5-year average of $780117.6 and a median of $794000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) soared 127.67% in 2022 and fell 16.65% in 2026, its largest moves.
- Tracing RPID's Depreciation & Amortization (CF) over 5 years: stood at $860000.0 in 2022, then dropped by 7.67% to $794000.0 in 2023, then advanced by 9.45% to $869000.0 in 2024, then retreated by 9.09% to $790000.0 in 2025, then decreased by 10.63% to $706000.0 in 2026.
- Business Quant data shows RPID's Depreciation & Amortization (CF) at $706000.0 in Q1 2026, $790000.0 in Q4 2025, and $804000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 706,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 706,000.00 |
| Mar 31, 2026 | 706,000.00 |
| Dec 31, 2025 | 790,000.00 |
| Dec 31, 2025 | 790,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Mar 31, 2025 | 847,000.00 |
| Mar 31, 2025 | 847,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Sep 30, 2024 | 859,000.00 |
| Sep 30, 2024 | 859,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Dec 31, 2023 | 794,000.00 |
| Dec 31, 2023 | 794,000.00 |